Top experts by indication / Oncology
Most active experts in Multiple Myeloma
2026 edition, data as of October 25, 2026
595 key opinion leaders in the directory are tagged to Multiple Myeloma. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 332 of the 595 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Shaji KumarMayo Clinic, MN | 38 trials |
| 2 | Ravi VijWashington University School of Medicine in St. Louis, MO | 16 trials |
| 3 | Paul RichardsonDana-Farber Cancer Institute, MA | 14 trials |
| 4 | William BensingerSwedish Cancer Institute, WA | 14 trials |
| 5 | David AviganDana-Farber Cancer Institute, MA | 13 trials |
| 6 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 12 trials |
| 7 | Ruben NiesvizkyWeill Cornell Medicine, NY | 11 trials |
| 8 | Irene GhobrialDana-Farber Cancer Institute, MA | 11 trials |
| 9 | Andrzej JakubowiakUniversity of Chicago, IL | 11 trials |
| 10 | Sergio GiraltMemorial Sloan Kettering Cancer Center, NY | 10 trials |
| 11 | Bart BarlogieNY | 10 trials |
| 12 | Melissa AlsinaMoffitt Cancer Center, FL | 10 trials |
| 13 | Andrew YeeMassachusetts General Hospital, MA | 10 trials |
| 14 | Jesus BerdejaSarah Cannon Research Institute, TN | 10 trials |
| 15 | Craig HofmeisterEmory University, GA | 10 trials |
| 16 | Meletios DimopoulosNational and Kapodistrian University of Athens | 9 trials |
| 17 | Jeffrey ZonderWayne State University School of Medicine, MI | 9 trials |
| 18 | Noopur RajeMassachusetts General Hospital, MA | 9 trials |
| 19 | Angela DispenzieriMayo Clinic, MN | 8 trials |
| 20 | Mohamad HusseinUniversity of South Florida, FL | 8 trials |
| 21 | Carl LandgrenFL | 8 trials |
| 22 | Attaya SuvannasankhaIndiana University School of Medicine, IN | 8 trials |
| 23 | Nikhil MunshiDana-Farber Cancer Institute, MA | 8 trials |
| 24 | John DipersioWashington University School of Medicine, MO | 8 trials |
| 25 | Sagar LonialEmory University, GA | 7 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 121 of the 595 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Kenneth AndersonDana-Farber Cancer Institute, MA | 169,750 citations |
| 2 | Paul RichardsonDana-Farber Cancer Institute, MA | 132,822 citations |
| 3 | Meletios DimopoulosNational and Kapodistrian University of Athens | 129,563 citations |
| 4 | Thomas WalshCornell University, NY | 105,956 citations |
| 5 | Nikhil MunshiDana-Farber Cancer Institute, MA | 104,230 citations |
| 6 | Philippe MoreauCHU de Nantes | 103,109 citations |
| 7 | Angela DispenzieriMayo Clinic, MN | 100,475 citations |
| 8 | John DipersioWashington University School of Medicine, MO | 98,282 citations |
| 9 | Shaji KumarMayo Clinic, MN | 95,766 citations |
| 10 | Razelle KurzrockMedical College of Wisconsin, WI | 88,610 citations |
| 11 | Morie GertzMayo Clinic, MN | 84,365 citations |
| 12 | Bart BarlogieNY | 79,019 citations |
| 13 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 77,241 citations |
| 14 | Daniel WeisdorfUniversity of Minnesota Medical School, MN | 76,789 citations |
| 15 | Gareth MorganNYU Langone Health, NY | 72,482 citations |
| 16 | Sagar LonialEmory University, GA | 68,513 citations |
| 17 | Sergio GiraltMemorial Sloan Kettering Cancer Center, NY | 63,367 citations |
| 18 | Sundar JagannathIcahn School of Medicine at Mount Sinai, NY | 63,181 citations |
| 19 | Thomas WitzigMayo Clinic, MN | 62,686 citations |
| 20 | John HainsworthSarah Cannon Research Institute, TN | 58,030 citations |
| 21 | Mary HorowitzMedical College of Wisconsin, WI | 57,794 citations |
| 22 | David MaloneyFred Hutchinson Cancer Center, WA | 54,034 citations |
| 23 | Robert OrlowskiThe University of Texas MD Anderson Cancer Center, TX | 54,018 citations |
| 24 | Rafael FonsecaMayo Clinic, AZ | 51,290 citations |
| 25 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 50,317 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 84 of the 595 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | John DipersioWashington University School of Medicine, MO | 15 awards |
| 2 | Irene GhobrialDana-Farber Cancer Institute, MA | 12 awards |
| 3 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 11 awards |
| 4 | Daniel WeisdorfUniversity of Minnesota Medical School, MN | 10 awards |
| 5 | Richard JonesJohns Hopkins University School of Medicine, MD | 10 awards |
| 6 | Mary HorowitzMedical College of Wisconsin, WI | 8 awards |
| 7 | Nikhil MunshiDana-Farber Cancer Institute, MA | 8 awards |
| 8 | Ephraim FuchsJohns Hopkins University School of Medicine, MD | 7 awards |
| 9 | Edward StadtmauerUniversity of Pennsylvania, PA | 7 awards |
| 10 | David AviganDana-Farber Cancer Institute, MA | 7 awards |
| 11 | Joanne KurtzbergDuke University Medical Center, NC | 7 awards |
| 12 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 6 awards |
| 13 | Alexander StewartAZ | 6 awards |
| 14 | Robert OrlowskiThe University of Texas MD Anderson Cancer Center, TX | 6 awards |
| 15 | Kenneth AndersonDana-Farber Cancer Institute, MA | 6 awards |
| 16 | Thomas WitzigMayo Clinic, MN | 6 awards |
| 17 | Angela DispenzieriMayo Clinic, MN | 5 awards |
| 18 | Colleen DelaneyWA | 5 awards |
| 19 | John WagnerUniversity of Minnesota, MN | 5 awards |
| 20 | David PorterPA | 5 awards |
| 21 | Nilofer AzadJohns Hopkins University School of Medicine, MD | 5 awards |
| 22 | John GlaspyUniversity of California, Los Angeles, CA | 5 awards |
| 23 | Madhav DhodapkarFred Hutchinson Cancer Center, WA | 5 awards |
| 24 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 5 awards |
| 25 | Yi LinMayo Clinic, MN | 5 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 55 of the 595 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Shaji KumarMayo Clinic, MN | 449 contributions |
| 2 | Kenneth AndersonDana-Farber Cancer Institute, MA | 289 contributions |
| 3 | Thomas WitzigMayo Clinic, MN | 240 contributions |
| 4 | Yi LinMayo Clinic, MN | 226 contributions |
| 5 | Sundar JagannathIcahn School of Medicine at Mount Sinai, NY | 213 contributions |
| 6 | Partow KebriaeiThe University of Texas MD Anderson Cancer Center, TX | 202 contributions |
| 7 | Martha LacyMayo Clinic, MN | 198 contributions |
| 8 | John HainsworthSarah Cannon Research Institute, TN | 194 contributions |
| 9 | Gary SchillerUniversity of California, Los Angeles, CA | 193 contributions |
| 10 | Sikander AilawadhiMayo Clinic, FL | 185 contributions |
| 11 | Ravi VijWashington University School of Medicine in St. Louis, MO | 184 contributions |
| 12 | Ajay NookaEmory University, GA | 180 contributions |
| 13 | David SiegelJohn Theurer Cancer Center, NJ | 179 contributions |
| 14 | John DipersioWashington University School of Medicine, MO | 171 contributions |
| 15 | Alexander LesokhinMemorial Sloan Kettering Cancer Center, NY | 159 contributions |
| 16 | Noopur RajeMassachusetts General Hospital, MA | 157 contributions |
| 17 | Jason LukeStrand Therapeutics, PA | 154 contributions |
| 18 | Irene GhobrialDana-Farber Cancer Institute, MA | 151 contributions |
| 19 | Parameswaran HariObsidian Therapeutics, WI | 151 contributions |
| 20 | Muzaffar QazilbashThe University of Texas MD Anderson Cancer Center, TX | 148 contributions |
| 21 | Gareth MorganNYU Langone Health, NY | 143 contributions |
| 22 | Luciano CostaUniversity of Alabama at Birmingham, AL | 138 contributions |
| 23 | Charles LoprinziMayo Clinic, MN | 131 contributions |
| 24 | Sham MailankodyMemorial Sloan Kettering Cancer Center, NY | 130 contributions |
| 25 | Geoffrey UyWashington University School of Medicine, MO | 130 contributions |
Emerging
35 of the 595 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Othman AkhtarMedical College of Wisconsin, WI |
| Melissa AlsinaMoffitt Cancer Center, FL |
| Diana BasaliCleveland Clinic, OH |
| David ChittyNorthwell Health, NY |
| Diana CirsteaHarvard University, MA |
| Moses EvbuomwanUniversity of Iowa Health Care, IA |
| Omotayo FasanUniversity of Pennsylvania, NC |
| Peter ForsbergCO |
| Utkarsh GoelMN |
| Sagun GoyalSaint Louis University Hospital, MO |
| Hamza HassanRoswell Park Comprehensive Cancer Center, NY |
| Hitomi HosoyaCedars-Sinai Medical Center, CA |
| Thomas JandlStony Brook University Hospital, NY |
| Sakshi JasraUniversity of Vermont, VT |
| Tibor KovacsovicsOR |
| Arjun LakshmanAllegheny Health Network, PA |
| Tomer MarkKaryopharm Therapeutics, CO |
| Aasiya MatinMayo Clinic, MN |
| Sandra MazzoniCleveland Clinic, OH |
| Shonali MidhaHarvard University, MA |
| Sara MonaghanTX |
| Darren PanUniversity of California, San Francisco, CA |
| Michael PishvaianJohns Hopkins University School of Medicine, DC |
| Sneha PurveyME |
| Sandeep RajMemorial Sloan Kettering Cancer Center, NY |
How these tables are computed
The cohort is every profile in the directory tagged to Multiple Myeloma, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Multiple Myeloma profile in the directory